Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Risk Factors and Emerging Therapies in Amyotrophic Lateral Sclerosis
Natalia Nowicka, Jakub Juranek, Judyta K. Juranek, et al.
International Journal of Molecular Sciences (2019) Vol. 20, Iss. 11, pp. 2616-2616
Open Access | Times Cited: 91

Showing 1-25 of 91 citing articles:

Excitatory Amino Acid Transporters in Physiology and Disorders of the Central Nervous System
Anna R. Malik, Thomas E. Willnow
International Journal of Molecular Sciences (2019) Vol. 20, Iss. 22, pp. 5671-5671
Open Access | Times Cited: 140
The role of nitric oxide in brain disorders: Autism spectrum disorder and other psychiatric, neurological, and neurodegenerative disorders
Manish Kumar Tripathi, Maryam Kartawy, Haitham Amal
Redox Biology (2020) Vol. 34, pp. 101567-101567
Open Access | Times Cited: 123
Role of Alcohol Drinking in Alzheimer’s Disease, Parkinson’s Disease, and Amyotrophic Lateral Sclerosis
Bin Peng, Qiang Yang, Rachna B Joshi, et al.
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 7, pp. 2316-2316
Open Access | Times Cited: 122
Role of Edaravone as a Treatment Option for Patients with Amyotrophic Lateral Sclerosis
HaEun Cho, Surabhi Shukla
Pharmaceuticals (2020) Vol. 14, Iss. 1, pp. 29-29
Open Access | Times Cited: 89
Silence superoxide dismutase 1 (SOD1): a promising therapeutic target for amyotrophic lateral sclerosis (ALS)
Elena Abati, Nereo Bresolin, Giacomo P. Comi, et al.
Expert Opinion on Therapeutic Targets (2020) Vol. 24, Iss. 4, pp. 295-310
Open Access | Times Cited: 81
Molecular Targets of Cannabidiol in Experimental Models of Neurological Disease
Serena Silvestro, Giovanni Schepici, Placido Bramanti, et al.
Molecules (2020) Vol. 25, Iss. 21, pp. 5186-5186
Open Access | Times Cited: 72
Nearly 30 Years of Animal Models to Study Amyotrophic Lateral Sclerosis: A Historical Overview and Future Perspectives
Tiziana Bonifacino, Roberta Arianna Zerbo, Matilde Balbi, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 22, pp. 12236-12236
Open Access | Times Cited: 63
CRISPR/Cas9-mediated excision of ALS/FTD-causing hexanucleotide repeat expansion in C9ORF72 rescues major disease mechanisms in vivo and in vitro
Katharina E. Meijboom, Abbas Abdallah, Nicholas P. Fordham, et al.
Nature Communications (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 40
Neuropsychological and neurophysiological aspects of brain‐computer‐interface (BCI) control in paralysis
Ujwal Chaudhary, Natalie Mrachacz‐Kersting, Niels Birbaumer
The Journal of Physiology (2020) Vol. 599, Iss. 9, pp. 2351-2359
Open Access | Times Cited: 70
Role of Oxidative Stress on the Etiology and Pathophysiology of Amyotrophic Lateral Sclerosis (ALS) and Its Relation with the Enteric Nervous System
Laura López‐Pingarrón, Henrique Almeida, Marisol Soria-Aznar, et al.
Current Issues in Molecular Biology (2023) Vol. 45, Iss. 4, pp. 3315-3332
Open Access | Times Cited: 21
Dissecting the Relationship Between Neuropsychiatric and Neurodegenerative Disorders
Rohan Gupta, Dia Advani, Divya Yadav, et al.
Molecular Neurobiology (2023) Vol. 60, Iss. 11, pp. 6476-6529
Closed Access | Times Cited: 20
Modulation of the gut–brain axis via the gut microbiota: a new era in treatment of amyotrophic lateral sclerosis
Hong Du, Chi Zhang, Wenshuo Wu, et al.
Frontiers in Neurology (2023) Vol. 14
Open Access | Times Cited: 18
Machine learning hypothesis-generation for patient stratification and target discovery in rare disease: our experience with Open Science in ALS
Joseph Geraci, Ravi Bhargava, Bessi Qorri, et al.
Frontiers in Computational Neuroscience (2024) Vol. 17
Open Access | Times Cited: 6
p62: Friend or Foe? Evidences for OncoJanus and NeuroJanus Roles
Sonia Emanuele, Marianna Lauricella, Antonella D’Anneo, et al.
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 14, pp. 5029-5029
Open Access | Times Cited: 44
One-carbon epigenetics and redox biology of neurodegeneration
Fabio Coppedè
Free Radical Biology and Medicine (2020) Vol. 170, pp. 19-33
Closed Access | Times Cited: 43
11C‐PK11195 PET–based molecular study of microglia activation in SOD1 amyotrophic lateral sclerosis
Giacomo Tondo, Leonardo Iaccarino, Chiara Cerami, et al.
Annals of Clinical and Translational Neurology (2020) Vol. 7, Iss. 9, pp. 1513-1523
Open Access | Times Cited: 42
A Review of the Common Neurodegenerative Disorders: Current Therapeutic Approaches and the Potential Role of Bioactive Peptides
Kuldeep Singh, Jeetendra Kumar Gupta, Shivendra Kumar, et al.
Current Protein and Peptide Science (2024) Vol. 25, Iss. 7, pp. 507-526
Closed Access | Times Cited: 5
Skeletal Muscle-Restricted Expression of Human SOD1 in Transgenic Mice Causes a Fatal ALS-Like Syndrome
Lee J. Martin, Margaret Wong
Frontiers in Neurology (2020) Vol. 11
Open Access | Times Cited: 39
Reduced mitochondrial D-loop methylation levels in sporadic amyotrophic lateral sclerosis
Andrea Stoccoro, Adam R. Smith, Lorena Mosca, et al.
Clinical Epigenetics (2020) Vol. 12, Iss. 1
Open Access | Times Cited: 37
TDP-43 Mutation Affects Stress Granule Dynamics in Differentiated NSC-34 Motoneuron-Like Cells
Qiao Ding, Justin Chaplin, Matthew J. Morris, et al.
Frontiers in Cell and Developmental Biology (2021) Vol. 9
Open Access | Times Cited: 28
GPX4 deficiency-dependent phospholipid peroxidation drives motor deficits of ALS
Long‐Fang Tu, Tian-Ze Zhang, Yangfan Zhou, et al.
Journal of Advanced Research (2022) Vol. 43, pp. 205-218
Open Access | Times Cited: 22
Neurodegenerative disease and antioxidant biomarkers: A bidirectional Mendelian randomization study
Qianqian Zhang, Qingyang Li, Huihui Zhao, et al.
Frontiers in Neurology (2023) Vol. 14
Open Access | Times Cited: 11
Nanotheranostics revolutionizing neurodegenerative diseases: From precision diagnosis to targeted therapies
Riya Joshi, Hemi Missong, Jayapriya Mishra, et al.
Journal of Drug Delivery Science and Technology (2023) Vol. 89, pp. 105067-105067
Closed Access | Times Cited: 11
Resting-State EEG Oscillations in Amyotrophic Lateral Sclerosis (ALS): Toward Mechanistic Insights and Clinical Markers
James Chmiel, Marta Stępień-Słodkowska
Journal of Clinical Medicine (2025) Vol. 14, Iss. 2, pp. 545-545
Open Access
Head Injury and Amyotrophic Lateral Sclerosis: Population-Based Study from the National ALS Registry
Jaime Raymond, Ileana M. Howard, J.L. Berry, et al.
Brain Sciences (2025) Vol. 15, Iss. 2, pp. 143-143
Open Access
Page 1 - Next Page

Scroll to top